Bruce & Co’s AbbVie ABBV Stock Holding History

Bruce & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.6M	Hold	122,500	–	–	7.62%	2
2025 Q4	$28M	Sell	122,500 -5,000	-4%	-$1.14M	8.68%	1
2025 Q3	$29.5M	Hold	127,500	–	–	9.14%	1
2025 Q2	$23.7M	Hold	127,500	–	–	7.67%	3
2025 Q1	$26.7M	Sell	127,500 -10,000	-7%	-$1.94M	8.57%	2
2024 Q4	$24.4M	Sell	137,500 -9,000	-6%	-$1.65M	7.85%	3
2024 Q3	$28.9M	Sell	146,500 -15,000	-9%	-$2.8M	8.42%	2
2024 Q2	$27.7M	Buy	161,500 +23,500	+17%	+$3.89M	9.11%	3
2024 Q1	$25.1M	Hold	138,000	–	–	8.34%	3
2023 Q4	$21.4M	Sell	138,000 -25,000	-15%	-$3.64M	7.46%	3
2023 Q3	$24.3M	Sell	163,000 -28,743	-15%	-$4.22M	8.28%	2
2023 Q2	$25.8M	Hold	191,743	–	–	7.25%	3
2023 Q1	$30.6M	Sell	191,743 -10,757	-5%	-$1.64M	8.33%	3
2022 Q4	$32.7M	Sell	202,500 -21,000	-9%	-$3.22M	8.44%	3
2022 Q3	$30M	Hold	223,500	–	–	8.24%	2
2022 Q2	$34.2M	Sell	223,500 -20,000	-8%	-$3.06M	8.05%	3
2022 Q1	$39.5M	Sell	243,500 -60,000	-20%	-$8.72M	8.07%	3
2021 Q4	$41.1M	Hold	303,500	–	–	8.22%	3
2021 Q3	$32.7M	Sell	303,500 -64,626	-18%	-$7.38M	6.96%	6
2021 Q2	$41.5M	Hold	368,126	–	–	7.92%	4
2021 Q1	$39.8M	Buy	368,126 +40,000	+12%	+$4.28M	7.46%	4
2020 Q4	$35.2M	Buy	328,126 +5,577	+2%	+$536K	6.78%	5
2020 Q3	$28.3M	Hold	322,549	–	–	5.85%	8
2020 Q2	$31.7M	Buy	322,549 +64,749	+25%	+$5.7M	6.88%	4
2020 Q1	$19.6M	Hold	257,800	–	–	4.52%	11
2019 Q4	$22.8M	Hold	257,800	–	–	4.45%	10
2019 Q3	$19.5M	Buy	257,800 +3,000	+1%	+$206K	4.05%	11
2019 Q2	$18.5M	Sell	254,800 -17,115	-6%	-$1.35M	3.95%	11
2019 Q1	$21.9M	Hold	271,915	–	–	4.28%	11
2018 Q4	$25.1M	Hold	271,915	–	–	5.34%	7
2018 Q3	$25.7M	Hold	271,915	–	–	4.98%	6
2018 Q2	$25.2M	Hold	271,915	–	–	5.01%	6
2018 Q1	$25.7M	Buy	271,915 +39,000	+17%	+$4.28M	5.38%	5
2017 Q4	$22.5M	Hold	232,915	–	–	4.88%	7
2017 Q3	$20.7M	Hold	232,915	–	–	4.63%	7
2017 Q2	$16.9M	Hold	232,915	–	–	3.86%	8
2017 Q1	$15.2M	Hold	232,915	–	–	3.63%	10
2016 Q4	$14.6M	Hold	232,915	–	–	3.81%	9
2016 Q3	$14.4M	Hold	232,915	–	–	3.9%	9
2016 Q2	$14.4M	Hold	232,915	–	–	3.69%	10
2016 Q1	$13.3M	Hold	232,915	–	–	3.71%	10
2015 Q4	$13.8M	Hold	232,915	–	–	3.74%	9
2015 Q3	$12.7M	Hold	232,915	–	–	3.26%	8
2015 Q2	$15.6M	Hold	232,915	–	–	4.05%	5
2015 Q1	$13.5M	Hold	232,915	–	–	3.43%	7
2014 Q4	$15.2M	Buy	232,915 +1,615	+0.7%	+$102K	4.21%	6
2014 Q3	$13.2M	Hold	231,300	–	–	3.69%	7
2014 Q2	$13.1M	Hold	231,300	–	–	3.01%	9
2014 Q1	$11.9M	Hold	231,300	–	–	3.19%	9
2013 Q4	$12.2M	Sell	231,300 -3,000	-1%	-$147K	3.47%	8
2013 Q3	$9.69M	Hold	234,300	–	–	3.17%	9
2013 Q2	$9.69M	Buy	+234,300	New	+$10.2M	3.24%	9

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bruce & Co's ABBV Position: Q1 2026 in Review

Bruce & Co held its AbbVie (ABBV) position steady in Q1 2026 at 122,500 shares worth $26.6M. The position accounts for 7.62% of the portfolio, ranked #2.

Bruce & Co first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $41.5M in Q2 2021. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Bruce & Co held 122,500 shares of AbbVie worth $26.6M as of Q1 2026.
Bruce & Co left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 7.62% of Bruce & Co's portfolio in Q1 2026, its #2 holding.
Bruce & Co first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Bruce & Co's AbbVie position peaked at $41.5M in Q2 2021.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bruce & Co's 13F filing for Q1 2026, filed 14 May 2026.